CA2931280A1 - Application of laminin to corneal endothelial cell culture - Google Patents

Application of laminin to corneal endothelial cell culture Download PDF

Info

Publication number
CA2931280A1
CA2931280A1 CA2931280A CA2931280A CA2931280A1 CA 2931280 A1 CA2931280 A1 CA 2931280A1 CA 2931280 A CA2931280 A CA 2931280A CA 2931280 A CA2931280 A CA 2931280A CA 2931280 A1 CA2931280 A1 CA 2931280A1
Authority
CA
Canada
Prior art keywords
laminin
chain
seq
corneal endothelial
endothelial cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2931280A
Other languages
English (en)
French (fr)
Inventor
Noriko Koizumi
Naoki Okumura
Shigeru Kinoshita
Friedrich E. Kruse
Ursula SCHLOETZER-SCHREHARDT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Doshisha Co Ltd
Kyoto Prefectural PUC
Original Assignee
Senju Pharmaceutical Co Ltd
Doshisha Co Ltd
Kyoto Prefectural PUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Doshisha Co Ltd, Kyoto Prefectural PUC filed Critical Senju Pharmaceutical Co Ltd
Publication of CA2931280A1 publication Critical patent/CA2931280A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2931280A 2013-11-27 2014-11-26 Application of laminin to corneal endothelial cell culture Abandoned CA2931280A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013244972 2013-11-27
JP2013-244972 2013-11-27
PCT/JP2014/081917 WO2015080297A1 (en) 2013-11-27 2014-11-26 Application of laminin to corneal endothelial cell culture

Publications (1)

Publication Number Publication Date
CA2931280A1 true CA2931280A1 (en) 2015-06-04

Family

ID=52432880

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2931280A Abandoned CA2931280A1 (en) 2013-11-27 2014-11-26 Application of laminin to corneal endothelial cell culture

Country Status (10)

Country Link
US (1) US11624053B2 (https=)
EP (1) EP3074508B1 (https=)
JP (3) JP6470286B2 (https=)
CN (1) CN105814195A (https=)
BR (1) BR112016011096A2 (https=)
CA (1) CA2931280A1 (https=)
ES (1) ES2763433T3 (https=)
MX (1) MX2016006915A (https=)
RU (1) RU2704984C1 (https=)
WO (1) WO2015080297A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2788472T (lt) 2011-12-06 2019-04-10 Astellas Institute For Regenerative Medicine Kryptingos diferenciacijos būdas, skirtas ragenos endotelio ląstelių gamybai
EP3213761B1 (en) 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
CN121891508A (zh) 2014-10-31 2026-04-21 京都府公立大学法人 使用层粘连蛋白的新的角膜的治疗
JP6849957B2 (ja) * 2015-11-10 2021-03-31 国立大学法人京都大学 ラミニンフラグメント含有培地を用いる細胞培養方法
WO2017082026A1 (ja) * 2015-11-10 2017-05-18 日機装株式会社 細胞支持複合体および細胞支持複合体の製造方法
CA3052124C (en) * 2017-01-31 2024-06-25 Osaka University Method for controlling differentiation of pluripotent stem cells
US20210372995A1 (en) * 2017-10-22 2021-12-02 The Johns Hopkins University Biomimetic platforms to model vascular pathophysiology, diagnostics, and therapy
WO2019102593A1 (ja) * 2017-11-24 2019-05-31 株式会社Ihi 細胞培養装置
CN113015429A (zh) * 2018-10-02 2021-06-22 学校法人同志社 用于保存角膜内皮细胞的方法和容器
JP6664755B1 (ja) * 2018-10-02 2020-03-13 学校法人同志社 角膜内皮細胞を保存するための方法および容器
JPWO2020184605A1 (https=) * 2019-03-12 2020-09-17
JP2023025311A (ja) * 2020-02-05 2023-02-22 味の素株式会社 タンパク質の製造方法
CN112522179A (zh) * 2020-12-23 2021-03-19 江苏艾尔康生物医药科技有限公司 一种角膜内皮细胞的分离培养方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678783B1 (en) 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
JP3421217B2 (ja) 1995-11-20 2003-06-30 麒麟麦酒株式会社 Ｒｈｏ標的タンパク質Ｒｈｏキナーゼ
JP2000513220A (ja) 1996-06-05 2000-10-10 ザ ジェネラル ホスピタル コーポレイション ラミニン―５及び基底膜構造の形成
FR2765781B1 (fr) 1997-07-08 1999-09-24 Gioia Bruno Di Procede de fabrication d'un accessoire de mode, dispositif pour la mise en oeuvre du procede et accessoire de mode ainsi realise
US6042262A (en) 1997-07-29 2000-03-28 Stryker Technologies Corportion Apparatus for storing, mixing, and dispensing two-component bone cement
US6693169B1 (en) 1998-10-13 2004-02-17 The General Hospital Corporation Laminin 5, 13 and 14 and uses thereof
JP2002542824A (ja) 1999-04-30 2002-12-17 バイオストラタム インコーポレイテッド 組換えラミニン５
US6635616B2 (en) 2000-05-01 2003-10-21 The General Hospital Corporation Laminin 15
WO2002050111A2 (en) 2000-12-21 2002-06-27 Biostratum, Inc. Isolated laminin 10
US20030125344A1 (en) 2001-03-23 2003-07-03 Bayer Corporation Rho-kinase inhibitors
MXPA03008659A (es) 2001-03-23 2005-04-08 Bayer Ag Inhibidores de rho-cinasa.
CN100411686C (zh) 2001-04-11 2008-08-20 千寿制药株式会社 视觉功能障碍改善剂
JPWO2002100833A1 (ja) 2001-06-12 2004-09-24 住友製薬株式会社 Ｒｈｏキナーゼ阻害剤
DE60320933D1 (de) 2002-01-10 2008-06-26 Bayer Healthcare Ag Rho-kinase inhibitoren
MXPA04007196A (es) 2002-01-23 2005-06-08 Bayer Pharmaceuticals Corp Inhibidores de rho-quinasa.
CA2483659A1 (en) * 2002-04-30 2003-11-13 Amniotec Inc. Corneal endothelium-like sheet and method of constructing the same
JP2004024852A (ja) 2002-04-30 2004-01-29 Amniotec:Kk 角膜内皮様シート、及びその作製方法
AU2003281623B8 (en) 2002-07-22 2009-06-11 Asahi Kasei Pharma Corporation 5-substituted isoquinoline derivative
CA2400996A1 (en) 2002-09-03 2004-03-03 Lisa Mckerracher 1,4-substituted cyclohexane derivatives
US7160894B2 (en) 2003-06-06 2007-01-09 Asahi Kasei Pharma Corporation Tricyclic compound
CA2530389A1 (en) 2003-07-02 2005-01-13 Biofocus Discovery Limited Pyrazine and pyridine derivatives as rho kinase inhibitors
US20050182061A1 (en) 2003-10-02 2005-08-18 Jeremy Green Phthalimide compounds useful as protein kinase inhibitors
ES2387780T3 (es) 2003-10-06 2012-10-01 Glaxosmithkline Llc Preparación de azabencimidazoles 1,6-disustituidos como inhibidores de quinasas
EP1689393A4 (en) 2003-10-06 2008-12-17 Glaxo Group Ltd PREPARATION OF 1,7-DISUBSTITUTED AZABENZIMIDAZOLES AS KINASE INHIBITORS
EP1670466A4 (en) 2003-10-06 2007-04-25 Glaxo Group Ltd PREPARATION OF 1,6,7-TRISUBSTITUTED AZABENIC ZIMIDAZOLES AS KINASE-INHIBITORS
CA2542041C (en) 2003-10-10 2014-12-09 Cellular Bioengineering, Inc. Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants
CN100560142C (zh) * 2003-10-10 2009-11-18 细胞生物工程公司 用于在生物聚合物上培养角膜内皮细胞和相关细胞以及产生人工角膜移植物的方法和组合物
KR20070053152A (ko) 2003-10-10 2007-05-23 셀룰라 바이오엔지니어링 인코포레이티드 인간의 각막 내피세포 및 각막세포 이식을 위한 세포배양및 수득방법
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
EP2468729B1 (en) 2003-10-15 2013-12-25 Ube Industries, Ltd. Novel indazole derivative
JP2007015928A (ja) 2003-10-15 2007-01-25 Ube Ind Ltd 新規オレフィン誘導体
BRPI0507074A (pt) 2004-01-23 2007-06-19 Advanced Cell Tech Inc modalidades aperfeiçoadas para o tratamento de doenças degenerativas da retina
WO2005087250A1 (en) 2004-02-12 2005-09-22 GOVERNMENT OF THE UNITED STATES OF AMERICA, as respresented by Secretary, Department of Health and Human Services Therapeutic administration of the scrambled anti-angiogenic peptide c16y
WO2005080394A1 (en) 2004-02-24 2005-09-01 Bioaxone Therapeutique Inc. 4-substituted piperidine derivatives
KR20070002081A (ko) 2004-04-02 2007-01-04 버텍스 파마슈티칼스 인코포레이티드 Ｒｏｃｋ 및 기타 단백질 키나아제의 억제제로서 유용한아자인돌
JPWO2006057270A1 (ja) 2004-11-26 2008-06-05 旭化成ファーマ株式会社 含窒素３環化合物
KR101149954B1 (ko) 2005-08-30 2012-06-01 아사히 가세이 파마 가부시키가이샤 술폰아미드 화합물
WO2007083685A1 (ja) 2006-01-19 2007-07-26 Senju Pharmaceutical Co., Ltd. 生体内で細胞増殖可能な角膜内皮製剤
WO2007091790A1 (en) 2006-02-07 2007-08-16 Korea Institute Of Radiological & Medical Sciences A composition for treating damage of central or peripheral nerve system
US20100028407A1 (en) 2006-04-27 2010-02-04 University Of Louisville Research Foundation, Inc. Layered bio-adhesive compositions and uses thereof
US8951799B2 (en) 2007-01-04 2015-02-10 Biolamina Ab Composition and method for enabling proliferation of pluripotent stem cells
KR20210070407A (ko) * 2007-08-29 2021-06-14 센주 세이야꾸 가부시키가이샤 각막 내피 세포 접착 촉진제
US20090306772A1 (en) 2008-04-18 2009-12-10 The Regents Of The University Of California Ocular Scaffolds and Methods for Subretinal Repair of Bruch's Membrane
US8680182B2 (en) 2009-06-04 2014-03-25 Clemson University Research Foundation Methods for promoting the revascularization and reenervation of CNS lesions
WO2010140464A1 (ja) 2009-06-05 2010-12-09 国立大学法人 熊本大学 細胞の分化誘導方法
JP5590646B2 (ja) * 2009-10-08 2014-09-17 国立大学法人大阪大学 ヒト多能性幹細胞用培養基材およびその利用
RU2418067C1 (ru) 2009-12-03 2011-05-10 Государственное образовательное учреждение высшего профессионального образования "Оренбургский государственный университет" Способ культивирования клеток
WO2011080984A1 (en) 2009-12-29 2011-07-07 Senju Pharmaceutical Co., Ltd. Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction
CN103384680B (zh) 2010-12-17 2015-08-26 拜奥拉米那公司 细胞培养基
WO2012173207A1 (ja) 2011-06-14 2012-12-20 独立行政法人理化学研究所 網膜細胞への分化誘導方法
US9347041B2 (en) * 2011-07-15 2016-05-24 Osaka University Method for preparing corneal endothelial cell
WO2013047763A1 (ja) 2011-09-29 2013-04-04 オリエンタル酵母工業株式会社 ラミニン５１１を含んだ系で哺乳類細胞を培養する方法
TWI719277B (zh) 2011-11-14 2021-02-21 美商安斯泰來再生醫藥協會 人類rpe細胞之醫藥組合物及其用途
JP5985207B2 (ja) 2011-11-25 2016-09-06 住友化学株式会社 網膜色素上皮細胞の製造方法
KR102111936B1 (ko) 2011-11-25 2020-05-18 스미또모 가가꾸 가부시끼가이샤 망막 조직 및 망막 관련 세포의 제조 방법
LT2788472T (lt) * 2011-12-06 2019-04-10 Astellas Institute For Regenerative Medicine Kryptingos diferenciacijos būdas, skirtas ragenos endotelio ląstelių gamybai
US9351914B2 (en) 2012-03-25 2016-05-31 The Board Of Trustees Of The Leland Stanford Junior University Methods for modulating hair growth using truncated laminin-511
EP2925856B1 (en) 2012-12-03 2018-03-07 Biolamina AB Methods of producing rpe cells
US11492593B2 (en) 2013-10-09 2022-11-08 Healios K.K. Method for purification of retinal pigment epithelial cells
CN121891508A (zh) 2014-10-31 2026-04-21 京都府公立大学法人 使用层粘连蛋白的新的角膜的治疗
EP3213761B1 (en) 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
AU2019291955A1 (en) 2018-06-29 2021-02-18 Platelet Biogenesis, Inc. Compositions for drug delivery and methods of use thereof

Also Published As

Publication number Publication date
BR112016011096A2 (pt) 2017-09-19
EP3074508B1 (en) 2019-11-06
JP6470286B2 (ja) 2019-02-13
JP2020188778A (ja) 2020-11-26
WO2015080297A1 (en) 2015-06-04
JP2016539641A (ja) 2016-12-22
RU2704984C1 (ru) 2019-11-01
ES2763433T3 (es) 2020-05-28
CN105814195A (zh) 2016-07-27
MX2016006915A (es) 2017-01-23
JP2019054828A (ja) 2019-04-11
EP3074508A1 (en) 2016-10-05
US20170002318A1 (en) 2017-01-05
RU2016125225A (ru) 2018-01-09
US11624053B2 (en) 2023-04-11

Similar Documents

Publication Publication Date Title
US11624053B2 (en) Application of laminin to corneal endothelial cell culture
RU2718062C2 (ru) Новое лечение роговицы с применением ламинина
US11918630B2 (en) Treatment of retina and nerve using laminin
Lee et al. Nidogen is a prosurvival and promigratory factor for adult Schwann cells
KR20180052946A (ko) 동물세포 배양용 무혈청 배지
WO2015015655A1 (ja) フックス角膜内皮ジストロフィ不死化細胞株およびその作製法
Igoucheva et al. Protein therapeutics for Junctional Epidermolysis bullosa: incorporation of recombinant β3 chain into laminin 332 in β3-/-keratinocytes in vitro
Hazra et al. In vitro profiling of the extracellular matrix and integrins expressed by human corneal endothelial cells cultured on silk fibroin-based matrices
Wu et al. Co-culture of RhoA-overexpressed microtia chondrocytes and adipose-derived stem cells in the construction of tissue-engineered ear-shaped cartilage
CN100513418C (zh) 促进细胞粘附和扩散的肽、其片段和衍生物
JP5882198B2 (ja) ラミニン５を含んだ系で細胞を培養する方法
Nguyen Determining the Effects of Recombinant Lysyl Oxidase on Tendon Mechanical Properties and Cell Behaviors
Lingling et al. Recombinant human bone morphogenetic protein-7 enhances bone formation ability of jaw bone defect using human umbilical cord mesenchymal stem cells combined with nano-hydroxyapatite/collagen/poly (L-lactide)
Li et al. Promotion of minTBP-1-PRGDN on the attachment, proliferation and collagen I synthesis of human keratocyte on titanium
Lo Disease Predilection and Molecular Heterogeneity of the Murine Aorta are Intrinsic to the Vessel Wall
Deister Neurotrophic factor combinations and extracellular matrix-based hydrogels for nerve regeneration

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20210217